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Abstract: Guanine nucleotide regulatory proteins (G-proteins) play a key role in the regulation of various signal transduc-
tion systems including adenylyl cyclase/cAMP and phospholipase C (PLC)/phosphatidyl inositol turnover (PI). These are 
implicated in the modulation of a variety of physiological functions such as platelet functions, cardiovascular functions, 
including arterial tone and reactivity. Several abnormalities in adenylyl cyclase activity, cAMP levels and G proteins have 
shown to be responsible for the altered cardiac performance and vascular functions observed in cardiovascular disease 
states. The enhanced or unaltered levels of inhibitory G-proteins (Gi-2 and Gi-3) and mRNA have been reported in dif-
ferent models of hypertension, whereas Gs levels were shown to be unaltered. These changes in G-protein expression 
were associated with Gi functions. The enhanced levels of Gi proteins precede the development of blood pressure and 
suggest that overexpression of Gi proteins may be one of the contributing factors for the pathogenesis of hypertension. 
The augmented levels of vasoactive peptides, including angiotensin II (AngII), were shown to contribute to enhanced ex-
pression of Gi proteins and associated adenylyl cyclase signaling and thereby increased blood pressure. In addition, en-
hanced oxidative stress in hypertension due to Ang II may also be responsible for the enhanced expression of Gi proteins 
observed in hypertension. The mechanism by which oxidative stress enhances the expression of Gi proteins appears to be 
through the activation of mitogen activated protein (MAP) kinase activity.  
Keywords: G-proteins, Angiotensin II, oxidative stress, MAPkinase, adenylyl cyclase, hypertension.  
INTRODUCTION 
  Guanine nucleotide regulatory proteins (G-proteins) are a 
family of guanosine triphosphate (GTP) binding proteins that 
play a key regulatory role as transducers in a variety of sig-
nal transduction system. These include adenylyl cy-
clase/cAMP system [1], the receptor-mediated activation of 
phospholipase C and A2 [2,3] and a number of hormone-and 
neurotransmitter-regulated ionic channels [4,5]. G proteins 
are heterotrimeric proteins composed of three distinct 
subunits; ,  and  [6]. The -subunits bind and hydrolyse 
GTP and confer specificity in receptor and effector interac-
tions [6]. The GDP bound form of  binds tightly to  and 
is inactive, whereas the GTP bound form of  dissociates 
from  and serves as a regulator of effector proteins. All -
subunits possess intrinsic GTPase activity and hydrolyse the 
terminal phosphate of bound GTP to yield bound GDP and 
free inorganic phosphate (Pi). Upon hormone binding and 
receptor activation, the receptor interacts with the hetero-
trimeric protein to promote a conformational change and 
dissociation of bound GDP from the guanine nucleotide 
binding site. GDP is released and replaced by GTP. Binding 
of GTP to  induces a conformational change and promotes 
the dissociation of hormone receptor complex (HR) and the 
holo G protein into  and . Both -GTP and  subunits 
can interact with effectors. This activation cycle is termi-
nated by intrinsic GTPase activity of -subunit. The GDP-
bound form of - subunit has high affinity for  andthen 
reassociates with the  dimmer to form the hetero 
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trimer in the basal resting state. The family of G-protein -
subunits can be subclassified according to functional or 
structural relationship. More than 20 mammalian G gene 
products and several alternatively spliced isoforms have 
been identified. These can be divided into four major sub-
families according to amino acid homology and are repre-
sented by Gs, Gi, Gq/11 and 12/13. The G proteins 
Gs and Gi are implicated in the regulation of adenylyl 
cyclase/cAMP signal transduction system.  
  The hormone-sensitive adenylyl cyclase system is com-
posed of three components: the receptor, the catalytic 
subunit, and G-proteins – stimulatory (Gs) and inhibitory 
(Gi). Molecular cloning has revealed four different forms of 
Gs having molecular weights of 45, 45, 52 kD resulting 
from the different splicing of one gene [7-9]. Gs is posi-
tively coupled to adenylyl cyclase and mediates the stimula-
tory responses of hormones on adenylyl cyclase [10,11]. The 
Gs-mediated activation of adenylyl cyclase results in the 
increase formation of cAMP. cAMP activates cAMP-
dependent protein kinase A that induces the phosphorylation 
of contractile filaments, sarcolemmal and sarcoplasmic pro-
teins, and regulates intracellular calcium homeostasis [12]. 
In addition, Gs was also shown to open the Ca
2+ channels 
directly by a cAMP-independent mechanism [13]. In con-
trast, Gi protein is associated with adenylyl cyclase inhibi-
tion [10,11]. Three distinct forms of Gi, namely, Gi-1, Gi-
2, and Gi-3 have been cloned and encoded by three distinct 
genes [14-16]. All three forms of Gi (Gi1-3) have been 
shown to be implicated in adenylyl cyclase inhibition [17] 
and activation of atrial Ach-K
+ channels [18]. Both the G 
and G dimer mediate G-protein signaling. Five different  
subunits of 35-36 kDa and 12  subunits of 8-10 kDa have 
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associated with GDP bound chain and facilitate the interac-
tion of G-protein with a receptor molecule. The effectors 
regulated by G include K
+ channels, phospholipase C-, 
and adenylyl cyclase [19-21].  
 G-protein  -subunits also possess specific residues that 
can be covalently modified by bacterial toxins. Cholera toxin 
catalyzes the transfer of ADP-ribose moiety of NAD to a 
specific arginine residue in certain -subunits, whereas per-
tussis toxin ADP-ribosylates those -subunits that contain a 
specific cysteine residue near to the carboxy terminus. Modi-
fication of -subunit by cholera toxin persistently activates 
these protein by inhibiting their GTPase activity, whereas 
pertussis toxin inactives Gi protein and thereby results in 
the uncoupling of receptor from the effector.  
G-PROTEINS AND MEMBRANE SIGNALING IN 
CARDIOVASCULAR DISEASE 
  A number of cardiovascular disease states that eventually 
result in chronic congestive heart failure are associated with 
alterations in cardiac performance. Several hormonal factors 
such as angiotensin II, endothelin and alterations in signal 
transduction mechanisms including adenylyl cyclase and 
phospholipase C (PLC) have been reported to play an impor-
tant role in the alterations of cardiac performance [22]. 
G-PROTEINS AND MEMBRANE SIGNALING IN 
HYPERTENSION 
  Alterations in G-protein levels and functions such as 
altered adenylyl cyclase responsiveness to various agonists 
have also been demonstrated in cardiovascular and non car-
diovascular tissues from genetic as well as experimental 
hypertensive rats [23-28].  
  An overexpression of Gi-2 and Gi-3 proteins as well as  
their genes was shown in hearts and aorta from spontane-
ously hypertensive rats (SHRs), deoxycorticosterone acetate 
(DOCA)-salt hypertensive rats (HR), N-[Omega]-nitro-L-
arginine methylester, (L-NAME) HR and 1 kidney 1 clip 
(1K1C) HR [23-33], whereas Gs protein and its gene was 
not altered in SHRs, 1K1C and L-NAME HR, and was de-
creased in DOCA-salt HRs [23-25,28,31-33].  In addition, 
the levels of Go in hearts from SHR were unaltered [24]. 
Alterations in Gi-protein levels have been shown to be re-
flected in altered responsiveness of adenylyl cyclase to 
stimulatory and inhibitory hormones in SHRs, and experi-
mental models of hypertensive rats [24,26,27,31-33].  How-
ever, a decreased expression of Gi proteins was also shown 
in different tissues from different model of HR including 
Milan hypertensive rats (MHS) [34-36].  The VSMC from 
MHS exhibit enhanced basal adenylyl cyclase activity as 
compared to control normotensive rats (MNS).  The number 
of -adrenoceptors and the stimulations exerted by isoproter-
enol and prostaglandin E1 (PGE1) were significantly in-
creased in MHS than in MNS.  On the other hand, platelets 
from SHRs [26] as well as from hypertensive patients [37] 
exhibited a decreased expression of Gi-2 and Gi-3 protein 
as compared to Wistar-Kyoto (WKY) and to normotensive 
control subjects, respectively whereas the levels of Gs pro-
tein were not altered. The decreased expression of Gi-2 and 
Gi-3 was correlated with adenylyl cyclase inhibition by 
inhibitory hormones.  The ANP and Ang II-mediated inhibi-
tions were completely attenuated in platelets from SHRs and 
hypertensive patients, whereas the stimulatory effects of 
PGE1, NECA and forskolin were augmented [26,37].  How-
ever, McLellan et al. [38] were unable to show any changes 
in the levels of Gs, Gi-2 and G in platelets from hyper-
tensive patients as compared to normotensive subjects, 
whereas an enhanced stimulation of adenylyl cyclase by 
PGE1 was observed in hypertensive patients as compared to 
normotensive subjects. On the other hand, lymphocytes from 
SHRs [39] and hypertensive patients [40] showed a de-
creased responsiveness of adenylyl cyclase to stimulatory 
hormones, which may be attributed to the alterations in Gs 
and Gi proteins.  The potentiation of stimulatory responses 
of several hormones on adenylyl cyclase has also been dem-
onstrated in platelets and splenocytic membranes from SHRs 
[41,42].  In addition, antihypertensive drug therapy (a com-
bination of -blockers Ca
2+ channel blocker, ACE inhibitor, 
etc.) partially restored Gi-2 levels and the enhanced stimula-
tions exerted by hormones toward normotensive subjects 
[37]. These effects on platelet function may underlie the 
beneficial effects of antihypertensive agents on some of the 
complications of hypertension.   
  In addition, the levels of Gs, Gi1-3, Go, and G were 
also shown to be unaltered in myocardium from SHRs, 
whereas hormonal stimulations of adenylyl cyclase were re-
duced in SHRs, and FSK-stimulated enzyme activity was 
greater in SHRs as compared to WKY [43]. The reduction in 
the hormone receptor binding sites may be one of the possible 
mechanisms responsible for such an impaired response of 
hormones [44-46]. However, the decreased stimulation of 
adenylyl cyclase by dopamine D-1 receptors in the kidney 
tubules from SHRs was shown to be attributed to the defective 
coupling and not to the changes in the receptor number [47]. 
   Furthermore, the increased levels of Gi were shown to 
be associated with hypertension and not with hypertrophy, 
due to the fact that heart and aorta from N-nitro-L-arginine 
methyl ester-(L-NAME)-induced hypertensive rats, which do 
not have cardiac hypertrophy exhibited enhanced levels of 
Gi-2 and Gi-3 proteins as well as mRNA, whereas the lev-
els of Gs protein were unaltered [31]. The increased levels 
of Gi-2  and Gi-3 proteins and their mRNA in heart and 
aorta precedes the development of blood pressure in SHRs 
[48], and in DOCA-salt hypertensive rats [49], and suggest 
that the enhanced levels of Gi proteins which result in the 
decreased levels of cAMP may be one of the contributing 
factors in the pathogenesis of hypertension. This was further 
supported by the recent studies showing that the inactivation 
of Gi protein in prehypertensive rats (2 week old SHR) by a 
single injection of pertussis toxin (PT) (1.5 μg/100 gm body 
weight) prevented the development of high blood pressure 
which was associated with PT-induced decreased levels of 
Gi proteins [50]. Furthermore, Triggle et al. [51] have also 
shown that treatment of the SHRs (adult) with PT lowered 
blood pressure. 
ROLE OF ENDOGENOUS ANGIOTENSIN II IN EN-
HANCED EXPRESSION OF GI PROTEINS IN HY-
PERTENSION 
  The levels of vasoactive peptides such as angiotensin II 
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as well as growth factors that have been reported to be aug-
mented in various models of hypertension [52- 60], may be 
responsible for the enhanced expression of Gi proteins in 
hypertension. In this regard, a role of Ang II in enhanced 
expression of Gi protein in SHR and 1K1C hypertensive 
rats (HR) has been suggested by the studies showing that 
captopril; an angiotensin coverting enzyme (ACE) inhibitor 
treatment of the SHR and 1K1C HR that decreased the blood 
pressure also restored the enhanced levels of Gi protein to 
control levels (Fig. 1). Similarly, the increased blood pres-
sure and enhanced expression of Gi proteins in L-NAME 
hypertensive rats was also shown to be restored to control 
levels by losartan, an AT1 receptor antagonist (Fig. 1) sug-
gesting the implication of Ang II in increased levels of Gi 
proteins and increased blood pressure in L-NAME-induced 
hypertension. These treatments were also shown to restore 
the diminished stimulation of adenylyl cyclase by stimula-
tory hormones and enhanced inhibition by inhibitory hor-
mones observed in SHRs, 1K1C and L-NAME HR [32, 
61,62]. In addition, infusion of Ang II in rats that increased 
blood pressure has also been reported to enhance the levels 
of Gi proteins [63]. Similarly, nitrendipin and fosinopril 
treatments have also been reported to have similar effects on 
Gi proteins and functions in hearts from SHRs [64] and fur-
ther support the implication of Ang II in enhanced levels of 
Gi protein in SHR.  
ROLE OF OXIDATIVE STRESS IN ENHANCED EX-
PRESSION OF GI PROTEINS IN HYPERTENSION 
  Reactive oxygen species (ROS) such as O2
-, OH
- and 
H2O2 that cause oxidative stress have been shown to play a 
major role in the pathophysiology of cardiovascular diseases 
including hypertension [65]. NADPH oxidase is the enzyme 
responsible for the formation of O2
- from the O2 molecule. 
Vascular NADPH oxidase is multimeric protein complex 
composed of at least 4 components: cell membrane-asso-
ciated p
22phox and gp
91phox (or gp
91phox  [Nox
2] homologues, 
nox1 and nox4), and cytosolic subunits, p47phox and 
p67phox [66,67]. The levels of ROS, have been shown to be 
augmented in spontaneous (genetic) SHR and experimental 
hypertension as well as in patients with various hypertensive 
disorders [68-76]. In addition, the enhanced expression of 
different subunits of NADPH oxidase such as p
47phox, Nox
4, 
p
2phox that has been shown in several tissues from SHR [72, 
75,76], appear to be responsible for the enhanced activity of 
NADPH oxidase and ROS production in SHR.  
  We showed recently that VSMC from SHR exhibit en-
hanced levels of O2
- [77] which were attenuated by AT1 
receptor antagonist, losartan (Fig. 2). In addition, the expres-
sion of p
47phox and Nox
4 was also augmented in these cells as 
shown in Fig. (3) [78]. Ang II, whose levels are augmented 
in hypertension, has been shown to be one of the important 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. (1). Effect of Captopril and losartan treatment on blood pressure and the expression of Gi proteins in different models of hypertensive 
rats (HR). 12 week-old SHR and age-matched WKY rats, 1 kidney 1 clip hypertensive rats (1K1C HR) were treated with captopril 
(150mg/kgB.W/day) as described earlier [32,61] whereas L-NAME-induced hypertensive rats were treated with losartan (10mg/kg B.W/day) 
as described earlier [62]. The blood pressure was monitored by the tail cuff method. The expression of Gi-2 and Gi-3 protein in heart from 
SHR and L-NAME HR and aorta from 1K1C HR were determinated by Western blotting using antibodies AS/7 and EC/1 against Gi-2 and 
Gi-3 protein respectively. The blots are representative of 4 separate experiments. 
**P<0.01, 
***P<0.001 vs control/WKY, 
††P<0.01, 
†††P<0.001 vs SHR/1K1C/L-NAME. 
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factors regulating NADPH oxidase. In this regard treatment 
of A10 VSMC with AngII has been shown to augment the 
production of O2
-  and the expression of Nox
4 and p
47phox 
proteins of NADPH oxidase [79]. In addition, we also 
showed that the enhanced levels of Gi proteins in SHR may 
also contribute to the enhanced production of O2
-  and in-
creased NADPH oxidase activity, because pertussis toxin 
treatment of VSMC from SHR also attenuated the enhanced 
levels of O2
- and enhanced activity of NADPH oxidase to 
control WKY levels as shown in Fig. (4) [78]. Furthermore, 
the decreased levels of cAMP in VSMC from SHR have also 
been reported to contribute to the enhanced production of O2
- 
and increased activity of NADPH oxidase because the treat-
ment of VSMC from SHR with 8Br-cAMP, as well as with 
cAMP elevating agents such as isoproterenol and forskolin 
(FSK), restored the enhanced activity of NADPH oxidase 
and enhanced levels of O2
- (Fig. 5) and p
47phox and Nox
4 to 
control WKY levels (Fig. 6). In addition, a role of reduced 
levels of cAMP in enhanced oxidative stress was further 
supported by the fact that Ang II-evoked enhanced produc-
tion of O2
-, NADPH oxidase activity and enhanced levels of 
p47phox and Nox4 proteins were shown to be restored to 
control levels by 8Br-cAMP in A10 VSMC [80]. 
  The role of MAP kinase and PI3K signaling in Ang II-
induced enhanced levels of Gi proteins has also been re-
ported [79, 81]. In addition, MEK inhibitor PD98059 (Fig.7) 
as well as antioxidants such as diphenyleneiodonium (DPI) 
and N-acetyl cysteine (NAC) (Fig. 8) were also shown to 
restore the enhanced levels of Gi proteins in SHR to control  
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. (2). Effect of losartan on superoxide anion (O2
--) production in vascular smooth muscle cells (VSMC) from Wistar–Kyoto (WKY) and 
spontaneously hypertensive rats (SHR). VSMC from 12-week-old SHR and age-matched WKY rats were treated with 10
-5 mol/l losartan for 
24 h, and O2
-_ production was determined as described earlier [77]. Data presented as the mean ± SEM of 5 separate experiments. **P < 0.01 
versus WKY rats, #P < 0.05 versus SHR. Adapted from [77]. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. (3). The expression of Nox4 and p47 
phox protein in vascular smooth muscle cells (VSMC) from Wistar–Kyoto (WKY) and spontane-
ously hypertensive rats (SHR). Membrane proteins (30μg) were separated and transferred to nitrocellulose, which was then immunoblotted 
by using specific antibody against (A) p47 
phox (C-20) and (B) Nox4 (N-15). The dynein or -actin was used to assess the loading protein. 
The results are expressed as percentage of WKY rats taken as 100%. Values are means ± SE of 4 separate experiments. *p<0.05 vs WKY. 
Adapted from [78]. 302    Current Cardiology Reviews, 2010, Vol. 6, No. 4  Madhu B. Anand-Srivastava 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. (4). Effect of pertussis toxin treatment on superoxide anion (O2
-
) production (A) and NADPH oxidase activity (B) in vascular smooth 
muscle cells (VSMC) from 12-week-old spontaneously hypertensive rats (SHR) and age-matched Wistar-Kyoto (WKY) rats. VSMC from 
SHR and WKY rats were pretreated with 0.5g/ml pertussis toxin for 24 hr as described earlier [50] and O2
-
 production and NADPH oxidase 
activity was determined as described earlier [78]. Values are mean ± SEM of 3 separate experiments. **p<0.01, ***p < 0.001 vs WKY, 
p < 
0.05, 
 p<0.01 vs SHR. Adapted from [78]. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. (5). Effect of forskolin (FSK), isoproterenol (Iso) and 8Br-cAMP on superoxide anion (O2
-) production in vascular smooth muscle cells 
(VSMC) from 12-week-old spontaneously hypertensive rat (SHR) and age matched Wistar-Kyoto (WKY) rats. VSMC from SHR and WKY 
rats were pretreated with FSK (100 μM), Iso (50 μM) and 8Br-cAMP (0.5 mM) for 24 h, and O2
- production (A) and NADPH oxidase activ-
ity (B) was determined as described earlier [80] Values are mean ± SEM of 3 separate experiments. ***p < 0.001 vs WKY, ##p < 0.01, ###p 
< 0.001 vs SHR. Adapted from [80]. Modulation of Gi proteins in Hypertension: Role of Angiotensin II and Oxidative Stress  Current Cardiology Reviews, 2010, Vol. 6, No. 4    303 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. (6). Effect of forskolin (FSK), isoproterenol (Iso) and 8Br-cAMP on the levels of Nox4 and p
47phox protein expression in vascular smooth 
muscle cells (VSMC) from 12-week-old spontaneously hypertensive rats (SHR) and age matched Wistar-Kyoto (WKY) rats. VSMC from 
SHR and WKY rats were pretreated without (control) or with FSK (100 μM), Iso (50 μM) and 8Br cAMP (0.5 mM) for 24 hr. Membrane 
proteins (30 μg) were separated and transferred to nitrocellulose, which was then immunoblotted using specific antibodies against Nox4 (N-
15, A) and p
47phox (C-20,B) as described earlier [78] The Dynein or  actin was used to assess the loading of the protein. Immunoblots are 
representative of 4 separate experiments. Lower panels: the graph shows quantification of protein ratio of Nox
4/Dynein (A) or p
47phox/ actin 
bands by densitometric scanning. The results are expressed as percentage of WKY taken as 100%. Values are mean ± SEM of 4 separate 
experiments. **p < 0.01 vs WKY, #p < 0.05, ## < 0.01 vs SHR. Adapted from [78]. 304    Current Cardiology Reviews, 2010, Vol. 6, No. 4  Madhu B. Anand-Srivastava 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. (7). Effect of PD 98059 on Gi-2 and Gi-3 protein expression in VSMC from 12 week-old SHR and age-matched WKY rats. Confluent 
VSMC from SHR and WKY rats were treated with or without PD 98059 (10μM) for 24 hours at 37ºC. Membrane proteins (30 μg) were 
separated and transferred to nitrocellulose, which was then immunoblotted with specific antibodies against Gi-2 (A) and Gi-3 (B)  as de-
scribed earlier [77]. The blots are representative of three separate experiments. The graphs at lower panel show quantification of protein 
bands by densitometric scanning. The results are expressed as percentage of WKY control which has been taken as 100%. Values are mean ± 
S.E.M of 5 separate experiments 
*P < 0.05 , 
**P<0.01 vs WKY, 
§P < 0.05 vs SHR. . Adapted from [77]. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. (8). Effect of N-acetyl-L-cysteine (NAC) and diphenyleneiodonium (DPI).on Gi-2 and Gi-3 protein expression in vascular smooth 
muscle cells (VSMC) from 12 week-old SHR and age-matched WKY rats. Confluent VSMC from SHR and WKY rats were treated with 20 
mM NAC(A) or 10μM DPI(B) for 24 hours at 37ºC. Membrane proteins (30 μg) were separated and transferred to nitrocellulose, which was 
immunoblotted with antibodies AS/7 and EC/1 against Gi-2 and Gi-3 respectively  as described earlier [77] The blots are representative of 
5 separate experiments. The graphs at lower panel show quantification of protein bands by densitometric scanning. The results are expressed 
as percentage of WKY control which has been taken as 100%. Values are mean ± S.E.M of 5 separate experiments 
*P < 0.05 vs WKY, 
§§P < 
0.01 vs SHR. Adapted from [77]. Modulation of Gi proteins in Hypertension: Role of Angiotensin II and Oxidative Stress  Current Cardiology Reviews, 2010, Vol. 6, No. 4    305 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. (9). Effect of NAC and DPI on ERK 1/2 phosphorylation in vascular smooth muscle cells (VSMC) from 12 week-old SHR and WKY 
rats. Confluent VSMC from SHR and WKY rats were treated with 20 mM N-acetyl-L-cysteine (NAC) or 10 μM diphenyleneiodonium (DPI) 
for 24 hours at 37ºC. Cell lysates were immunoblotted by phospho-specif-Tyr
204-ERK1/2 antibodies as shown at the top panel. Blots were 
also analyzed for total ERK1/2 (bottom panel). The blots are representative of 3 separate experiments. Detection of p-ERK1/2 and total 
ERK1/2 was performed with chemiluminesecence Western blotting detection reagents. WKY levels were taken as 100%. Values are mean ± 
S.E.M of 3 separate experiments. 
**P<0.01, 
***P < 0.001 vs WKYand 
§§§P < 0.001 vs SHR. Adapted from [77]. 
 
WKY levels further suggest the implication of MAP kinase 
and oxidative stress in the enhanced expression of Gi pro-
tein in SHR [77]. Furthermore, VSMC from SHR exhibited 
the enhanced phosphorylation of ERK1/2 which was also 
restored to WKY levels by antioxidants (Fig. 9) [77] and 
suggest that enhanced oxidative stress through MAP kinase 
signaling may contribute to the enhanced expression of Gi 
protein in SHR (Fig. 10).  
CONCLUSIONS 
  In conclusion, we have discussed the alterations in G-
proteins and associated functions in hypertension. We have 
mainly focused on Gi and Gs proteins which are implicated 
in the regulation of the adenylyl cyclase/cAMP signal trans-
duction system that play an important role in the regulation 
of cardiovascular functions, including vascular tone and 
reactivity and cell proliferation. The levels of Gi-2 and Gi-
3 proteins and mRNA are increased in hearts and aorta from 
genetic and experimentally induced hypertensive rats, 
whereas the levels of Gs are unaltered in genetic and de-
creased in experimentally induced hypertensive rats with 
established hypertrophy. The increased levels of Gi-2 and 
Gi-3 are associated with increased Gi functions, resulting in 
greater decreases in cAMP levels, which may partly explain 
the increased vascular resistance in hypertension. On the 
other hand, the decreased levels of Gs and decreased forma-
tion of cAMP in hypertension associated with hypertrophy 
may also contribute to the increased vascular reactivity in 
hypertension. The increased levels of Gi-2 and Gi-3 may 
contribute to the pathogenesis of hypertension whereas de-
creased levels of Gs may be associated with hypertrophy 
and not with hypertension. This notion is substantiated by  
 
 
 
 
 
 
 
 
 
 
 
 
Fig. (10). Possible mechanisms involving angiotensin II and oxida-
tive stress in enhanced Gi protein expression in hypertension. Gi 
protein expression is enhanced in genetic (SHR) and experimental 
hypertension including 1 kidney 1 clip (1K1C) and L-NAME –
induced hypertension. Inhibition of nitric oxide synthase (NOS) by 
L-NAME activates renin angiotensin system, and also decreases the 
level of NO. 1K1C hypertensive rats also exhibit enhanced levels of 
AngII. Ang II increases oxidative stress that through increased 
MAP kinase activity results in enhanced expression of Gi proteins 
and thereby hypertension.  306    Current Cardiology Reviews, 2010, Vol. 6, No. 4  Madhu B. Anand-Srivastava 
our recent studies, showing that enhanced expression of Gi-
2 and Gi-3 proteins and mRNA precede the development of 
blood pressure. The role of enhanced levels of Gi proteins 
in the pathogenesis of hypertension was further supported by 
our studies showing that inactivation of Gi proteins by 
pertussis toxin treatment in prehypertensive SHR prevented 
the development of blood pressure. However, the levels of 
Gs were decreased only in 15 weeks of SHRs with estab-
lished hypertrophy. Similarly, L-NAME hypertensive rats 
that do not have cardiac hypertrophy exhibited enhanced 
expression of Gi-2 and Gi-3 and no changes in Gs, 
whereas hypertrophied rats with volume-overload hypertro-
phy, which do not have hypertension, exhibited decreased 
levels of Gs and no augmentation in Gi-2 or Gi-3 pro-
teins. The increased oxidative stress due to enhanced levels 
of endogenous vasoactive peptides including AngII through 
MAP kinase signaling, may contribute to the augmented 
levels of Gi proteins in SHR. Thus, taken together, it can be 
concluded that decreased formation of cAMP levels, either 
by increased levels and function of Gi or decreased levels of 
Gs and associated functions, may be responsible for the 
altered cardiac performance and vascular reactivity in car-
diovascular disease including hypertension. 
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